ProCE Banner Activity

Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: An Update from ASCO

Podcast Episodes

Listen as Beth Sandy, MSN, CRNP, discusses some of the latest key data on immune checkpoint inhibitors (ICIs) in non-small-cell lung cancer (NSCLC) reported at the American Society of Clinical Oncology (ASCO) Annual Conference.

Released: June 27, 2022

Expiration: June 26, 2023

Share

Faculty

Beth Sandy

Beth Sandy, MSN, CRNP, FAPO

Thoracic Oncology Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Acknowledgement

This activity is supported by educational grants from Bristol Myers Squibb; Genentech, a member of the Roche Group; Merck Sharp & Dohme Corp.; and Regeneron Pharmaceuticals, Inc and Sanofi.

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb

Genentech, a member of the Roche Group

Merck Sharp & Dohme Corp.

Regeneron Pharmaceuticals, Inc

Sanofi

Target Audience

Oncology NPs, PAs, and nurses

Disclosure

Beth Sandy, MSN, CRNP: consultant: Amgen, AstraZeneca, Janssen, Jazz, Merck, Takeda.

Format

Podcast

Additional Information

Program Medium

This program has been made available online.